Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
459 !
|
Wed, 7/31/2019,
8:30 AM -
10:20 AM
|
CC-111
|
|
Rethinking Intercurrent Events and Estimators Within the ICH E9(R1) Estimand Framework — Topic Contributed Papers
|
|
Biopharmaceutical Section, Biometrics Section, ENAR
|
|
Organizer(s): Dong Xi, Novartis
|
|
Chair(s): Forrest Williamson, Eli Lilly
|
|
8:35 AM
|
A Constructive Critique of the Draft ICH E9 Addendum
Daniel Scharfstein, Johns Hopkins School of Hygiene & Public Health
|
|
8:55 AM
|
Estimands in Clinical Trials with Intercurrent Events
Shanthi Sethuraman, Eli Lilly and Company; Yongming Qu, Eli Lilly and Company; Linda Shurzinske, Eli Lilly and Company
|
|
9:15 AM
|
Comparison of Assumptions Required for Estimating Different Parameters in the Presence of Intercurrent Events
Michael Rosenblum, Johns Hopkins Bloomberg School of Public Health
|
|
9:35 AM
|
Some Thoughts on Recurrent Event Estimands and Estimators
Dong Xi, Novartis; Jiawei Wei, Novartis; Tobias Muetze, Novartis
|
|
9:55 AM
|
Discussant: Thomas Permutt, U.S. Food and Drug Administration
|
|
10:15 AM
|
Floor Discussion
|
|
